SYDNEY, Australia and SAN DIEGO, Feb. 25, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company"), which is developing a novel bioresorbable slide and lock drug-eluting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback